BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 6805321)

  • 1. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three methods for detecting low-level bacterial contamination in intravenous solutions.
    Miller CM; Furtado D; Smith FM; Godwin HN; Hogan LC; Letendre DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1302-5. PubMed ID: 6812414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two methods for detecting microbial contamination in intravenous fluids.
    Posey LM; Nutt RE; Thomson PD
    Am J Hosp Pharm; 1981 May; 38(5):659-62. PubMed ID: 6792910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining a time frame for sterility testing of intravenous admixtures.
    DeChant RL; Furtado D; Smith FM; Godwin HN; Domann DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1305-8. PubMed ID: 6751079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adventitious contamination of intravenous admixtures during sterility testing.
    Bernick JJ; Brown DG; Bell JE
    Am J Hosp Pharm; 1979 Nov; 36(11):1493-6. PubMed ID: 517534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method for testing aseptic technique of intravenous admixture personnel.
    Dirks I; Smith FM; Furtado D; White SJ; Godwin HN
    Am J Hosp Pharm; 1982 Mar; 39(3):457-9. PubMed ID: 7041641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounding times and contamination rates associated with the preparation of intravenous admixtures in three types of plastic containers.
    Allinson RR; Stach PE; Sherrin TP; Latiolais CJ
    Am J Hosp Pharm; 1979 Apr; 36(4):513-7. PubMed ID: 433938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of bacteria in intravenous fluids under stimulated actual-use conditions.
    Hugbo PG; Imhanlahimi WA
    Am J Hosp Pharm; 1983 Jun; 40(6):998-1001. PubMed ID: 6408922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterility and use patterns of multiple-dose vials.
    Bawden JC; Jacobson JA; Jackson JC; Anderson RK; Burke JP
    Am J Hosp Pharm; 1982 Feb; 39(2):294-7. PubMed ID: 6800255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterility testing of antimicrobial-containing injectable solutions prepared in the pharmacy.
    Akers MJ; Wright GE; Carlson KA
    Am J Hosp Pharm; 1991 Nov; 48(11):2414-8. PubMed ID: 1746574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative sum control charts for admixture quality control.
    Sanford RL
    Am J Hosp Pharm; 1980 May; 37(5):655-9. PubMed ID: 7386472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viability of microorganisms in fluorouracil and cisplatin small-volume injections.
    Holmes CJ; Kubey WY; Love DI
    Am J Hosp Pharm; 1988 May; 45(5):1089-91. PubMed ID: 3400651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a device for monitoring sterility of injectable fluids.
    Mayhall CG; Pierpaoli PG; Hall GO; Thomas RB
    Am J Hosp Pharm; 1981 Aug; 38(8):1148-50. PubMed ID: 6791498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of microbial contamination during extended intravenous therapy using inline filters.
    Rusmin S; Althauser MB; DeLuca PP
    Am J Hosp Pharm; 1975 Apr; 32(4):373-7. PubMed ID: 805533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control of small-volume sterile products.
    Rupp CA; Kikugawa CA; Kotabe SE; Barriere SL; Bowman WD
    Am J Hosp Pharm; 1977 Jan; 34(1):47-9. PubMed ID: 318798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for testing the sterility of total nutrient admixtures.
    Levchuk JW; Nolly RJ; Lander N
    Am J Hosp Pharm; 1988 Jun; 45(6):1311-21. PubMed ID: 3137813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.